ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,454,705 | -12.4% | 90,446 | -0.8% | 0.00% | -100.0% |
Q2 2023 | $2,803,304 | +48.9% | 91,194 | +74.5% | 0.00% | – |
Q1 2023 | $1,882,567 | -98.6% | 52,250 | -98.5% | 0.00% | -100.0% |
Q4 2022 | $134,009,199 | -15.6% | 3,390,921 | -14.2% | 0.03% | -20.6% |
Q3 2022 | $158,756,000 | +12.2% | 3,951,117 | +17.4% | 0.03% | +21.4% |
Q2 2022 | $141,447,000 | +17.1% | 3,364,603 | +8.5% | 0.03% | +33.3% |
Q1 2022 | $120,769,000 | -2.4% | 3,099,830 | -0.2% | 0.02% | +5.0% |
Q4 2021 | $123,747,000 | +9.5% | 3,105,308 | -0.7% | 0.02% | +5.3% |
Q3 2021 | $113,061,000 | -35.9% | 3,128,405 | -27.3% | 0.02% | -34.5% |
Q2 2021 | $176,402,000 | -17.4% | 4,303,526 | -12.0% | 0.03% | -23.7% |
Q1 2021 | $213,436,000 | -27.3% | 4,893,133 | -16.6% | 0.04% | -29.6% |
Q4 2020 | $293,741,000 | +22.5% | 5,868,929 | +3.0% | 0.05% | +8.0% |
Q3 2020 | $239,804,000 | -11.9% | 5,700,113 | +1.7% | 0.05% | -18.0% |
Q2 2020 | $272,148,000 | – | 5,605,531 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |